{"id":"W3007085808","doi":"10.1002/ajh.25766","title":"Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Internal medicine; Ibrutinib; IGHV@; Rituximab; Oncology; Gastroenterology; Surgery; Chronic lymphocytic leukemia; Leukemia; Chemotherapy; Lymphoma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005639873,0.0002936781,0.002235687,0.0001098742,0.0001332274,0.0000293911,0.0003383704,0.00006608191,0.000009141941],"category_scores_gemma":[0.003829092,0.0001345043,0.0003207502,0.0003426752,0.001331366,0.00008308583,0.0000974187,0.0003513129,0.000002795986],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01315391,"about_ca_system_score_gemma":0.009738111,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001316052,"about_ca_topic_score_gemma":0.000225159,"domain_scores_codex":[0.9938681,0.002375135,0.002272193,0.00042418,0.0007098258,0.0003505551],"domain_scores_gemma":[0.9876288,0.008793566,0.002326019,0.0004192746,0.0006053664,0.0002269336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7232153,0.01642814,0.03117198,0.0007933631,0.02550495,0.001884429,0.0677169,0.00161925,0.0004977958,0.0006771187,0.02599565,0.1044951],"study_design_scores_gemma":[0.6657861,0.1292365,0.003449215,0.000167278,0.003104619,0.001229724,0.04726394,0.1469882,0.000205979,0.00002654177,0.002276677,0.0002651838],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871439,0.001543303,0.001084788,0.005852978,0.0001161127,0.004206134,0.00002400343,0.00001439209,0.00001442275],"genre_scores_gemma":[0.9982482,0.0002777066,0.0004445752,0.0005513495,0.0002132402,0.0001639258,0.00001410287,0.0000371875,0.00004970727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.145369,"threshold_uncertainty_score":0.9958758,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07603734731203367,"score_gpt":0.4028478104530401,"score_spread":0.3268104631410064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}